Stay updated on Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial
Sign up to get notified when there's something new on the Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial page.

Latest updates to the Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded a Locations section with new site listings in the US (Louisiana, Michigan, Ohio, Texas, Washington), Brazil (Rio Grande do Sul, São Paulo), and Mexico (Nuevo León); updated the page revision to v3.3.3 and removed some previous location blocks.SummaryDifference0.8%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange Detected- Revision updated from v3.2.0 to v3.3.2 on the page header. No study content or documents were modified.SummaryDifference0.0%

- Check45 days agoChange DetectedRemoved a site-wide notice about government funding and operating status. The change does not affect the study details, eligibility criteria, or core functionality of the page.SummaryDifference0.3%

- Check66 days agoChange DetectedScreenshots show only minor visual/layout adjustments with sections slightly rearranged; the substantive study information remains unchanged (overview, eligibility criteria, outcomes, and locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check88 days agoChange DetectedMajor changes: updated operating status notice and a version bump to v3.2.0. Minor or no other content changes are indicated.SummaryDifference0.7%

- Check95 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0, indicating a new version release.SummaryDifference0.0%

Stay in the know with updates to Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial page.